The global market for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform in Gastric Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform include AstraZeneca Plc, Bayer AG, Curis Inc, GlaxoSmithKline Plc, Karus Therapeutics Ltd, Novartis AG, PIQUR Therapeutics AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform.

The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Report

Report Metric	Details
Report Name	Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market
Segment by Type	PQR-514 KA-2237 GSK-2636771 BAY-1082439 Others
Segment by Application	Gastric Cancer Metastatic Colorectal Cancer Myelofibrosis Renal Cell Carcinoma Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca Plc, Bayer AG, Curis Inc, GlaxoSmithKline Plc, Karus Therapeutics Ltd, Novartis AG, PIQUR Therapeutics AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market report?

Ans: The main players in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market are AstraZeneca Plc, Bayer AG, Curis Inc, GlaxoSmithKline Plc, Karus Therapeutics Ltd, Novartis AG, PIQUR Therapeutics AG

What are the Application segmentation covered in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market report?

Ans: The Applications covered in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market report are Gastric Cancer, Metastatic Colorectal Cancer, Myelofibrosis, Renal Cell Carcinoma, Others

What are the Type segmentation covered in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market report?

Ans: The Types covered in the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market report are PQR-514, KA-2237, GSK-2636771, BAY-1082439, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 PQR-514

1.2.3 KA-2237

1.2.4 GSK-2636771

1.2.5 BAY-1082439

1.2.6 Others

1.3 Market by Application

1.3.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Gastric Cancer

1.3.3 Metastatic Colorectal Cancer

1.3.4 Myelofibrosis

1.3.5 Renal Cell Carcinoma

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Perspective (2020-2031)

2.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Growth Trends by Region

2.2.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Historic Market Size by Region (2020-2025)

2.2.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Region (2026-2031)

2.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Dynamics

2.3.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Industry Trends

2.3.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Drivers

2.3.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Challenges

2.3.4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players by Revenue

3.1.1 Global Top Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players by Revenue (2020-2025)

3.1.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Players (2020-2025)

3.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue

3.4 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Concentration Ratio

3.4.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue in 2024

3.5 Global Key Players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Head office and Area Served

3.6 Global Key Players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, Product and Application

3.7 Global Key Players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Breakdown Data by Type

4.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Historic Market Size by Type (2020-2025)

4.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Type (2026-2031)

5 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Breakdown Data by Application

5.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Historic Market Size by Application (2020-2025)

5.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2020-2031)

6.2 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025)

6.4 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2020-2031)

7.2 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025)

7.4 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2020-2031)

8.2 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2020-2025)

8.4 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2020-2031)

9.2 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025)

9.4 Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (2020-2031)

10.2 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025)

10.4 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca Plc

11.1.1 AstraZeneca Plc Company Details

11.1.2 AstraZeneca Plc Business Overview

11.1.3 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.1.4 AstraZeneca Plc Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.1.5 AstraZeneca Plc Recent Development

11.2 Bayer AG

11.2.1 Bayer AG Company Details

11.2.2 Bayer AG Business Overview

11.2.3 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.2.4 Bayer AG Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.2.5 Bayer AG Recent Development

11.3 Curis Inc

11.3.1 Curis Inc Company Details

11.3.2 Curis Inc Business Overview

11.3.3 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.3.4 Curis Inc Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.3.5 Curis Inc Recent Development

11.4 GlaxoSmithKline Plc

11.4.1 GlaxoSmithKline Plc Company Details

11.4.2 GlaxoSmithKline Plc Business Overview

11.4.3 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.4.4 GlaxoSmithKline Plc Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.4.5 GlaxoSmithKline Plc Recent Development

11.5 Karus Therapeutics Ltd

11.5.1 Karus Therapeutics Ltd Company Details

11.5.2 Karus Therapeutics Ltd Business Overview

11.5.3 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.5.4 Karus Therapeutics Ltd Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.5.5 Karus Therapeutics Ltd Recent Development

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.6.4 Novartis AG Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.6.5 Novartis AG Recent Development

11.7 PIQUR Therapeutics AG

11.7.1 PIQUR Therapeutics AG Company Details

11.7.2 PIQUR Therapeutics AG Business Overview

11.7.3 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Introduction

11.7.4 PIQUR Therapeutics AG Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

11.7.5 PIQUR Therapeutics AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Karus Therapeutics Ltd

Novartis

PIQUR Therapeutics AG

List of Tables

Table 1. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of PQR-514

Table 3. Key Players of KA-2237

Table 4. Key Players of GSK-2636771

Table 5. Key Players of BAY-1082439

Table 6. Key Players of Others

Table 7. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region (2020-2025)

Table 11. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region (2026-2031)

Table 13. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Trends

Table 14. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Drivers

Table 15. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Challenges

Table 16. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Restraints

Table 17. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Players (2020-2025)

Table 19. Global Top Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform as of 2024)

Table 20. Ranking of Global Top Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, Headquarters and Area Served

Table 23. Global Key Players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, Product and Application

Table 24. Global Key Players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2020-2025)

Table 28. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type (2026-2031)

Table 30. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2020-2025)

Table 32. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2026-2031)

Table 34. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2026-2031) & (US$ Million)

Table 49. AstraZeneca Plc Company Details

Table 50. AstraZeneca Plc Business Overview

Table 51. AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 52. AstraZeneca Plc Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 53. AstraZeneca Plc Recent Development

Table 54. Bayer AG Company Details

Table 55. Bayer AG Business Overview

Table 56. Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 57. Bayer AG Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 58. Bayer AG Recent Development

Table 59. Curis Inc Company Details

Table 60. Curis Inc Business Overview

Table 61. Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 62. Curis Inc Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 63. Curis Inc Recent Development

Table 64. GlaxoSmithKline Plc Company Details

Table 65. GlaxoSmithKline Plc Business Overview

Table 66. GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 67. GlaxoSmithKline Plc Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 68. GlaxoSmithKline Plc Recent Development

Table 69. Karus Therapeutics Ltd Company Details

Table 70. Karus Therapeutics Ltd Business Overview

Table 71. Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 72. Karus Therapeutics Ltd Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 73. Karus Therapeutics Ltd Recent Development

Table 74. Novartis AG Company Details

Table 75. Novartis AG Business Overview

Table 76. Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 77. Novartis AG Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 78. Novartis AG Recent Development

Table 79. PIQUR Therapeutics AG Company Details

Table 80. PIQUR Therapeutics AG Business Overview

Table 81. PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product

Table 82. PIQUR Therapeutics AG Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025) & (US$ Million)

Table 83. PIQUR Therapeutics AG Recent Development

Table 84. Research Programs/Design for This Report

Table 85. Key Data Information from Secondary Sources

Table 86. Key Data Information from Primary Sources

Table 87. Authors List of This Report

List of Figures

Figure 1. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Picture

Figure 2. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Type: 2024 VS 2031

Figure 4. PQR-514 Features

Figure 5. KA-2237 Features

Figure 6. GSK-2636771 Features

Figure 7. BAY-1082439 Features

Figure 8. Others Features

Figure 9. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Application: 2024 VS 2031

Figure 11. Gastric Cancer Case Studies

Figure 12. Metastatic Colorectal Cancer Case Studies

Figure 13. Myelofibrosis Case Studies

Figure 14. Renal Cell Carcinoma Case Studies

Figure 15. Others Case Studies

Figure 16. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Report Years Considered

Figure 17. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region: 2024 VS 2031

Figure 20. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Players in 2024

Figure 21. Global Top Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue in 2024

Figure 23. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2020-2031)

Figure 25. United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2020-2031)

Figure 29. Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Region (2020-2031)

Figure 37. China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2020-2031)

Figure 45. Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Country (2020-2031)

Figure 49. Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. AstraZeneca Plc Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 53. Bayer AG Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 54. Curis Inc Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 55. GlaxoSmithKline Plc Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 56. Karus Therapeutics Ltd Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 57. Novartis AG Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 58. PIQUR Therapeutics AG Revenue Growth Rate in Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions